Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
44.51
-0.49 (-1.09%)
At close: Jun 18, 2026, 4:00 PM EDT
44.70
+0.19 (0.43%)
After-hours: Jun 18, 2026, 7:36 PM EDT
Structure Therapeutics Employees
Structure Therapeutics had 220 employees as of December 31, 2025. The number of employees increased by 57 or 34.97% compared to the previous year.
Employees
220
Change (1Y)
57
Growth (1Y)
34.97%
Revenue / Employee
n/a
Profits / Employee
-$774,259
Market Cap
3.16B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| uniQure | 221 |
| Relay Therapeutics | 193 |
GPCR News
- 2 days ago - Structure Therapeutics Transcript: AGM 2026 - Transcripts
- 8 days ago - Structure Therapeutics price target lowered to $70 from $100 at H.C. Wainwright - TheFly
- 10 days ago - Structure Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 14 days ago - Structure's experimental obesity pill shows no signs of liver injury - Reuters
- 14 days ago - Structure Therapeutics announces ACCESS trial data published in Nature Medicine - TheFly
- 14 days ago - Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity - GlobeNewsWire
- 14 days ago - Structure Therapeutics Slides: Corporate presentation - Filings
- 16 days ago - Structure Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts